Metabolomics in various Diseases

Metabolomics is new omics platform that offers great potential for the diagnosis and prognosis of neurodegenerative diseases as an individual metabolome reflects alterations in genetic, transcript, and protein profiles and effects from the environment. Small numbers of metabolites have been used to diagnose complex metabolic diseases as well as monogenic disorders such as inborn errors of metabolism. Metabolic alterations in Cardiopulmonary Vascular Dysfunction are the leading purpose of death worldwide which is affecting the functions of the blood vessels and heart.

 

    Related Conference of Metabolomics in various Diseases

    September 21-21, 2021

    1st Webinar on Biosimilars

    London, UK
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland
    September 29-29, 2021

    27th Asia Pacific Biotechnology Congress

    London, UK
    November 18-19, 2021

    25th World Congress on Pharmaceutical Biotechnology

    Barcelona, Spain
    November 22-23, 2021

    23rd Global Biotechnology Congress

    Rome, Italy
    December 01-02, 2021

    18th International Conference on Metabolomics and Proteomics

    Frankfurt, Germany
    December 08-09, 2021

    World Congress on Biosensors and Bioelectronics

    London, UK
    December 08-08, 2021

    2nd International Conference on Nucleic Acids

    London, UK
    December 27-27, 2021

    12th Tissue Repair and Regeneration Congress

    Dubai, UAE
    December 30-30, 2021

    Glycobiology Biochem Conference 2021

    London, UK
    February 25-26, 2022

    International Conference on Biotechnology

    Singapore City,Singapore
    May 02-03, 2022

    12th World Glycobiology Congress

    Zurich, Switzerland
    August 22-23, 2022

    15th International Conference on Proteomics, Genomics & Bioinformatics

    Singapore City, Singapore

    Metabolomics in various Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in